PARIS, 04-Oct-2018 — /EuropaWire/ — Sanofi has completed the previously announced divestment of its European generics business Zentiva to Advent International (Advent) effective September 30. The transaction was finalized ahead of schedule for €1,9 billion (enterprise value). Sanofi announced the beginning … Read the full press release
Posted in Business, France, Pharma & Biotech
Tagged Advent, divestment, generics, Sanofi, Zentiva
PARIS, 28-Sep-2018 — /EuropaWire/ — Capgemini today announced that it has won a 2018 Systems Integrator Partner of the Year for Customer Impact award from Pivotal Software, Inc. Capgemini was honored with the prestigious award during SpringOne Platform in Washington, D.C for its work … Read the full press release
Posted in Awards, France, Pharma & Biotech, Technology
Tagged Award, Capgemini, DIFA, Fernando Alvarez, Nick Cayou, pharmacy, Pivotal, Pivotal Software
Fresh design and improved features to provide better user experience LONDON, 25-Sep-2018 — /EuropaWire/ — The European Medicines Agency (EMA) will launch a new version of its corporate website (www.ema.europa.eu) on 27 September 2018. The new website will have an improved … Read the full press release
Posted in Internet & Online, Pharma & Biotech, United Kingdom
Tagged EMA, European Medicines Agency, medicines, website
During the combined exhibition of the European Society of Cataract & Refractive Surgeons (ESCRS) and the European Society of Retina Specialists (EURETINA), ZEISS presents its cross-platform ophthalmic digital portfolio which aids doctors in disease management, allowing them to help their … Read the full press release
LJUBLJANA, Slovenia, 21-Sep-2018 — /EuropaWire/ — The latest study published in the World Journal of Urology (Comparison between erbium‑doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence – https://doi.org/10.1007/s00345-018-2445-x) provides further … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Slovenia, Technology
Tagged aesthetics, bladder, Chang Gung Memorial Hospital, Chang-Hua Hospital, clinical paper, dentistry, Dermatology, Dr. Adolf Lukanovic, Dr. Mija Blaganje, Dr. Nobuo Okui, Dr. Yi-Hao Lin, Dr. Yi-Wen Tien, dual-tissue regeneration, Dynamis XS, Er:YAG laser therapy, erbium‑doped yttrium aluminum garnet laser therapy, Fotona, Fotona d.o.o., Fotona SMOOTH® Er:YAG laser thermotherapy, Fotona SMOOTH® laser technology, Fotona SMOOTH® technology, genitourinary syndrome of menopause, gynecological treatment options, gynecologists, gynecology, ICIQ-SF, IncontiLase®, IncontiLase® Er:YAG, IncontiLase® Er:YAG laser therapy, International Consultation on Incontinence Questionnaire Short Form, laser irradiation, laser therapy, medical lasers, Non-ablative erbium yttrium aluminum garnet laser, non-invasive treatment of SUI, One-hour pad test, overactive bladder, Overactive bladder symptom score, patient safety, pelvic organ prolapse, premenopausal parous women, ProlapLase®, RenovaLase®, stress, study, SUI, SUI symptoms, superficial heat-shocking mechanism, surgery, surgical sling procedures, Tension-free vaginal tape, tension-free vaginal tape - TVT, thermotherapy, tissue regeneration, TOT procedures, Transobturator tape, transobturator tape - TOT, TVT procedures, urinary incontinence, urodynamic stress incontinence, vaginal collagen hyperthermia, vaginal laxity – vaginal relaxation syndrome, vaginal tissues, vaginal wall, World Journal of Urology
Researchers at the University of Cambridge and the University of Oxford have discovered a new molecule that plays a key role in the immune response that is triggered by influenza infections. The molecule, a so-called mini viral RNA, is capable … Read the full press release
Goldschmidt: “I look forward to working with the highly experienced team at STADA and continuing the Group’s long-term growth” Supervisory Board Chairman von Au: “Goldschmidt is the right man that STADA needs to ensure the Group successfully retains its strong … Read the full press release
Posted in Germany, Management, Pharma & Biotech
Tagged Claudio Albrecht, Peter Goldschmidt, STADA Arzneimittel AG
New treatment might have the potential to slow or stop the progression of Parkinson’s disease. VALBY, 12-Sep-2018 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck) begins clinical development of yet another potential new treatment of Parkinson’s disease with the enrollment of the … Read the full press release
Posted in Denmark, Healthcare, Pharma & Biotech
Tagged antibody, brain_cells, Genmab, Lundbeck, Parkinson's, Parkinson's disease, proteins
AstraZeneca’s first Breakthrough Therapy Designation for a respiratory medicine Designation based on Phase IIb PATHWAY data that demonstrated tezepelumab significantly reduced asthma exacerbations compared to placebo in severe asthma CAMBRIDGE, 12-Sep-2018 — /EuropaWire/ — AstraZeneca and its partner Amgen Inc. (Amgen) … Read the full press release
Posted in Healthcare, Pharma & Biotech
Tagged Amgen, asthma, AstraZeneca, breakthrough therapy designation, eosinophilic_phenotype, medicine, respiratory, Sean Bohen, tezepelumab
Ensuring capacity for temperature-controlled overland services 35 new trailers facilitating intermodal KN PharmaChain connection SCHINDELLEGI, Switzerland, 05-Sep-2018 — /EuropaWire/ — With the ongoing market growth for temperature-controlled shipments, Kuehne + Nagel is investing in its European Pharma fleet to strengthen the … Read the full press release
Approval based on COMBI-AD study demonstrating greater than 50% reduction in risk of disease recurrence or death in stage III melanoma patients More than 50% of stage III melanoma patients are likely to recur to stage IV during their lifetime … Read the full press release
Posted in European Union, Healthcare, Pharma & Biotech, Switzerland
Tagged BRAFmutation, dabrafenib, inhibitor, Mekinist®, melanoma, Novartis, Tafinlar®, trametinib, tumor
Decision based on five-year data from COMPASS-XT long-term safety study Alcon advises ophthalmic surgeons to cease further implantation BASEL, 31-Aug-2018 — /EuropaWire/ — Reflecting its uncompromising commitment to patient safety, Alcon today announced an immediate, voluntary market withdrawal of the CyPass Micro-Stent from … Read the full press release
Posted in Healthcare, Pharma & Biotech, Retail, Switzerland
Tagged Alcon, cataract, CyPass® Micro-Stent, glaucoma, market_withdrawal, safety
AMSTERDAM, 31-Aug-2018 — /EuropaWire/ — At a time when health systems and healthcare professionals are under more pressure than ever to do more with less, the promise of intelligent technology that can deliver life-changing insights from all our data is … Read the full press release
AMSTERDAM, 31-Aug-2018 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired Xhale Assurance Inc, a US-based scale-up company developing and commercializing next-generation sensor technologies. Xhale Assurance’s unique, disposable pulse oximetry … Read the full press release
iFR-guided strategy now deemed beneficial in the assessment of the functional significance of intermediate coronary stenosis Technique using iFR-guided strategy is non-inferior to FFR for guiding decisions for intervening on immediate lesions with stable angina or NSTE ACS MUNICH, 31-Aug-2018 … Read the full press release
The EC approval is based on the first global CAR-T registration trials, which included patients from eight European countries and demonstrated durable responses and a consistent safety profile in r/r pediatric B-cell ALL and r/rDLBCL Novartis is the only company with an approved … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged CTL019, European Commission, Kymriah, leukemia, lymphoblastic, lymphoblastic_leukemia, Novartis, tisagenlecleucel
SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients with PIK3CA mutations who progressed on or following treatment with an aromatase inhibitor with or without a CDK4/6 inhibitor[1] Approximately 40% of HR+ advanced breast cancer … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged breast_cancer, BYL719, Cancer, inhibitor, Novartis, oncology, PI3K
Brentford, United Kingdom, 14-Aug-2018 — /EuropaWire/ — GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Iain Mackay has been appointed GSK’s next Chief Financial Officer (CFO). He has also been appointed as an Executive Director to the GSK Board. Mr Mackay will … Read the full press release
Posted in Healthcare, Management, Pharma & Biotech, United Kingdom
Tagged appointment, CFO, Emma Walmsley, GSK, Healthcare, Iain Mackay, leadership, Management, pharma, Philip Hampton, Simon Dingemans
MUNICH, 14-Aug-2018 — /EuropaWire/ — Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer’s disease and type 2 diabetes are not yet available. Scientists at the Technical University of Munich (TUM) have now come a little bit closer to … Read the full press release
Rxulti® (brexpiprazole) has been approved for the treatment of schizophrenia in adults. VALBY, 01-Aug-2018 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the European Commission has approved Rxulti® (brexpiprazole) for the treatment of schizophrenia … Read the full press release
Posted in Denmark, Healthcare, Pharma & Biotech
Tagged brexpiprazole, European Commission, H. Lundbeck A/S, Ltd, Lundbeck, Otsuka, Otsuka Pharmaceutical Co., Rxulti, schizophrenia
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?